Scientific Reports (Jul 2017)

Human Platelet Lysate versus Fetal Calf Serum: These Supplements Do Not Select for Different Mesenchymal Stromal Cells

  • Eduardo Fernandez-Rebollo,
  • Birgit Mentrup,
  • Regina Ebert,
  • Julia Franzen,
  • Giulio Abagnale,
  • Torsten Sieben,
  • Alina Ostrowska,
  • Per Hoffmann,
  • Pierre-François Roux,
  • Björn Rath,
  • Michele Goodhardt,
  • Jean-Marc Lemaitre,
  • Oliver Bischof,
  • Franz Jakob,
  • Wolfgang Wagner

DOI
https://doi.org/10.1038/s41598-017-05207-1
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Culture medium of mesenchymal stromal cells (MSCs) is usually supplemented with either human platelet lysate (HPL) or fetal calf serum (FCS). Many studies have demonstrated that proliferation and cellular morphology are affected by these supplements – it is therefore important to determine if they favor outgrowth of different subpopulations and thereby impact on the heterogeneous composition of MSCs. We have isolated and expanded human bone marrow-derived MSCs in parallel with HPL or FCS and demonstrated that HPL significantly increases proliferation and leads to dramatic differences in cellular morphology. Remarkably, global DNA-methylation profiles did not reveal any significant differences. Even at the transcriptomic level, there were only moderate changes in pairwise comparison. Furthermore, the effects on proliferation, cytoskeletal organization, and focal adhesions were reversible by interchanging to opposite culture conditions. These results indicate that cultivation of MSCs with HPL or FCS has no systematic bias for specific cell types.